Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kempf

Showing results (271-280 of 415) with videos related to

Pageof 42
Sort By:
Journal of Occupational Medicine and Toxicology (London, England)|October 1, 2021
Powered air-purifying respirators used during the SARS-CoV-2 pandemic significantly reduce speech perceptionRoxanne Weiss, Leon Guchlerner, Tobias Weissgerber, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 7, 2021
Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infectionRoxanne Weiss, Leon Guchlerner, Andreas G Loth, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742Tatyana Dekhtyar, Teresa I Ng, Liangjun Lu, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 27, 2020
[SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area]Andreas A Schnitzbauer, Volkhard A J Kempf, Daniel Hack, et al.
Science (New York, N.Y.)|August 3, 1990
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 proteaseJ Erickson, D J Neidhart, J VanDrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Cell Reports|July 21, 2021
Heterogeneity of neurons reprogrammed from spinal cord astrocytes by the proneural factors Ascl1 and Neurogenin2J Kempf, K Knelles, B A Hersbach, et al.
Travel Medicine and Infectious Disease|February 19, 2022
External ophthalmomyiasis by Oestrus ovis in tourists visiting Italy. Report of three cases and a literature reviewClaudia Tamponi, Cinzia Pasini, Fahad Ahmed, et al.
BMC Infectious Diseases|May 1, 2019
Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organismsDoris Fischer, Rolf L Schlößer, Volkhard A J Kempf, et al.
Pageof 42

Showing results (271-280 of 415) with videos related to

Sort By:
Pageof 42
Journal of Occupational Medicine and Toxicology (London, England)|October 1, 2021
Powered air-purifying respirators used during the SARS-CoV-2 pandemic significantly reduce speech perceptionRoxanne Weiss, Leon Guchlerner, Tobias Weissgerber, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 7, 2021
Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infectionRoxanne Weiss, Leon Guchlerner, Andreas G Loth, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742Tatyana Dekhtyar, Teresa I Ng, Liangjun Lu, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 27, 2020
[SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area]Andreas A Schnitzbauer, Volkhard A J Kempf, Daniel Hack, et al.
Science (New York, N.Y.)|August 3, 1990
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 proteaseJ Erickson, D J Neidhart, J VanDrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Cell Reports|July 21, 2021
Heterogeneity of neurons reprogrammed from spinal cord astrocytes by the proneural factors Ascl1 and Neurogenin2J Kempf, K Knelles, B A Hersbach, et al.
Travel Medicine and Infectious Disease|February 19, 2022
External ophthalmomyiasis by Oestrus ovis in tourists visiting Italy. Report of three cases and a literature reviewClaudia Tamponi, Cinzia Pasini, Fahad Ahmed, et al.
BMC Infectious Diseases|May 1, 2019
Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organismsDoris Fischer, Rolf L Schlößer, Volkhard A J Kempf, et al.
Pageof 42